PGP and neoplasm: Of interest is that cisplatin is not a substrate of P-gp, yet we have shown elsewhere [9] that its intracellular residence time is also increased by tetrac, raising the possibility of multiple mechanisms by which tetrac affects tumor cell handling of anticancer drugs.